Position in CELC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,424,085
+$6,424,085 QoQ
Shares Held
61,404
Ownership
0.125%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#80
of 274 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in CELC
reported options exposure · as of Mar 31, 2026CallValue
$924,534
CallShares
8,100
PutValue
$2,282,800
PutShares
20,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026NOMURA HOLDINGS INC holds $218,808,046 across 46 Biotechnology names. CELC ranks #10 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
402,192 | $31,889,803 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
327,475 | $24,390,338 | |
| 3 | LGND |
Ligand Pharmaceuticals Inc
|
61,938 | $19,577,982 | |
| 4 | AUPH |
Aurinia Pharmaceuticals Inc.
|
978,602 | $16,606,875 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
417,932 | $15,216,904 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
29,198 | $14,503,522 | |
| 7 | OABI |
OmniAb, Inc.
|
5,028,160 | $12,369,273 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,320 | $8,929,092 |
All Filings in CELC
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,424,085 | 61,404 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,282,800 | 20,000 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $924,534 | 8,100 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $807,894 | 8,100 | Call | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||